Research Overview
Across the studies reviewed here, coconut oil research is most developed in topical dermatologic and neonatal applications. Two randomized, double-blind controlled trials in adults evaluated virgin coconut oil (VCO) as a moisturizer: one in mild–moderate xerosis comparing VCO with mineral oil over 2 weeks using objective biophysical measures (hydration, skin lipids, TEWL, pH), and one in atopic dermatitis (AD) comparing VCO with virgin olive oil over 4 weeks assessing Staphylococcus aureus (SA) colonization and objective severity (O-SSI). In neonatology, two randomized trials examined coconut oil massage/skin care in preterm and term infants, focusing on growth velocity/weight gain and skin integrity outcomes. In contrast, the cognitive study cited used coconut oil only as a placebo comparator for fish oil supplementation rather than testing coconut oil’s cognitive effects directly.
The strongest evidence in these studies supports coconut oil as an effective and apparently safe topical emollient, with efficacy comparable to mineral oil for xerosis and no signal of barrier harm over short follow-up (no significant changes in TEWL or pH; no adverse reactions reported in patch-tested participants). In AD, VCO showed stronger evidence for reducing SA colonization than olive oil and was associated with greater improvement in objective severity scores, suggesting potential antimicrobial or colonization-reducing benefit alongside moisturization. In preterm/term infants, randomized trials suggest coconut oil skin application/massage may improve weight gain relative to control/placebo and may help maintain skin integrity; however, neurobehavioral outcomes (Brazelton scores) did not differ in the study that assessed them.
Key gaps include limited sample sizes, short intervention periods, and restricted populations and settings, which constrain generalizability and long-term safety conclusions. More research is needed to clarify mechanisms (e.g., barrier lipid effects vs antimicrobial activity), to compare coconut oil against standard-of-care emollients and antiseptic strategies in AD, and to determine optimal dosing, formulation (virgin vs refined), and durability of effects. In neonates, larger, blinded trials with standardized massage protocols and clinically important endpoints (e.g., infection rates, dermatitis, longer-term growth and neurodevelopment) are needed, as are safety evaluations in very preterm or medically fragile infants. Finally, the cognitive domain remains essentially unaddressed for coconut oil itself in these studies, since it served only as a placebo; dedicated studies would be required to assess any neurocognitive effects.
1. What conditions has Coconut Oil been studied for?
Mild to moderate xerosis (dry skin) as a topical moisturizer (virgin coconut oil vs mineral oil) over 2 weeks.
Atopic dermatitis (AD) in adults, focusing on skin dryness/severity and Staphylococcus aureus (S. aureus) colonization (virgin coconut oil vs virgin olive oil) over 4 weeks.
Preterm and term infant growth/skin outcomes with coconut oil massage/skin care, including:
Growth velocity (weight and length) and neurobehavior (Brazelton score) in term and preterm infants (coconut oil vs mineral oil vs placebo powder) through 31 days.
Skin integrity and weight gain in preterm neonates in NICU (coconut oil vs sunflower seed oil vs control) through 1 month post-discharge.
As a placebo comparator in a young-adult cognition trial of fish oil (coconut oil used as placebo for 4 weeks). This study primarily evaluates fish oil, not coconut oil as an active treatment.
2. Does it work in treating those conditions? Summarize the evidence.
-
Xerosis (dry skin): Yes, as a moisturizer, with evidence comparable to mineral oil.
In a randomized double-blind trial (n=34), both coconut oil and mineral oil significantly improved skin hydration and increased skin surface lipids over 2 weeks.
Objective safety markers (transepidermal water loss and skin pH) showed no significant differences, and there were no adverse reactions reported during the study.
Subjective ratings trended slightly better with coconut oil, but not statistically significant.
-
Atopic dermatitis (AD) and S. aureus colonization: Evidence suggests benefit, particularly for reducing S. aureus colonization and improving severity scores.
In a double-blind controlled trial (26 per group), among those colonized at baseline, post-treatment S. aureus positivity dropped to 5% (1/20) with VCO vs 50% (6/12) with VOO; reported relative risk 0.10 (p = .0028; 95% CI 0.01–0.73) and number needed to treat 2.2.
Objective SCORAD severity index (O-SSI) improved in both groups, but improvement was significantly greater with VCO post-treatment (p = .004).
Limitations: modest sample size; baseline colonization rates differed between groups (more colonized participants in the VCO arm), and the study does not detail concomitant AD therapies.
-
Preterm/term infant growth and skin integrity: Evidence suggests benefit for weight gain and skin condition when used topically/massage.
Open randomized trial: coconut oil massage led to greater weight gain velocity in preterm infants vs mineral oil and placebo; in term infants vs placebo. Preterm infants also had greater length gain velocity vs placebo. No significant neurobehavioral differences were detected.
NICU RCT (n=66): at 1 month post-discharge, both coconut oil and sunflower seed oil groups weighed significantly more than controls (P = .004), and skin condition scores favored the oil groups vs control (P = .000). Coconut oil was not clearly superior to sunflower seed oil in the study.
Limitations: one study was open-label (higher risk of bias); outcomes may be influenced by feeding practices and other neonatal care factors not described in the studies.
-
Cognition in young adults: No evidence of cognitive benefit from coconut oil in these studies; it served as a placebo comparator in a fish oil trial. The placebo group (coconut oil) showed some improvements likely attributable to learning effects, not a demonstrated therapeutic effect of coconut oil.
3. What health benefits does it have?
-
Topical moisturizing/barrier support for dry skin: In xerosis, coconut oil improved objective measures of hydration and skin surface lipids, performing similarly to mineral oil in a double-blind trial.
-
Potential antimicrobial/anti-colonization effect in AD: In adults with atopic dermatitis, VCO substantially reduced S. aureus colonization compared with virgin olive oil and improved objective severity scores more than olive oil.
-
Neonatal skin integrity support and possible growth benefit (topical use): In preterm neonates, coconut oil skin care/massage was associated with better skin condition and greater weight gain compared with control/placebo in randomized studies.
Important scope note: These studies primarily support topical benefits (skin and neonatal outcomes). They do not provide evidence for broad systemic benefits from dietary coconut oil.
4. Does it have any downsides or side effects?
-
Skin irritation/allergy (appears uncommon in these studies): In the xerosis trial, participants had negative patch tests to the products and there were no adverse reactions during 2 weeks of use. This supports short-term tolerability in a selected population, but does not rule out reactions in the general population.
-
Barrier disruption concerns not supported here: The xerosis trial measured TEWL and skin pH and found no significant safety differences versus mineral oil, suggesting no measurable barrier harm over the study period.
-
Evidence gaps/limitations:
Most data are short-term (2–4 weeks; neonatal follow-up to 1 month post-discharge).
Neonatal massage study was open-label, which can bias outcomes.
These studies do not address potential downsides of oral coconut oil intake (e.g., lipid changes), because oral intake was not the intervention studied.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
The studies reviewed here do not report any pharmacogenomic analyses or genotype-stratified outcomes for coconut oil (topical or oral). Therefore:
No evidence from these studies that coconut oil is specifically beneficial or harmful based on genetic variation.
Unknown/unstudied in these studies: whether variants affecting skin barrier function, innate immunity, or lipid metabolism modify response to topical coconut oil.
References
-
A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis
Anna Liza C Agero, Vermén M Verallo-Rowell (2004) -
Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis
Vermén M Verallo-Rowell, Kristine M Dillague, Bertha S Syah-Tjundawan (2008) -
Omega-3 polyunsaturated fatty acids and cognition in a college-aged population
Justin E Karr, Tyler R Grindstaff, Joel E Alexander (2012) -
Oil massage in neonates: an open randomized controlled study of coconut versus mineral oil
K Sankaranarayanan, J A Mondkar, M M Chauhan, B M Mascarenhas, A R Mainkar (2005) -
Comparison of Coconut and Sunflower Seed Oils in Improving the Skin Integrity and Weight Gain of Infants in the Neonatal ICU
Öznur Tiryaki, Hamide Zengin, Nursan Çınar, Meltem Karabay, İbrahim Caner (2024)
This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!